Luis Correia

Luis Correia

Luis Correia is currently Director at Roche Pharma Partnering in Switzerland. He has led several acquisitions and licensing deals for Roche including the acquisition of the gene therapy company Spark Therapeutics and a collaboration with Regeneron on covid-19 antibodies. He is also the representative of Roche Pharma Partnering in Baselaunch, a start-up incubator based in Basel. Prior to working in Partnering, Luis worked at Roche Pharma Finance and Investor Relations. His previous work experience includes 10 years at Credit Suisse as Pharma and Biotech Analyst and Fund manager. He is a graduate of Chemical Engineering from Tecnico in Lisbon, has a PhD in Organic Chemistry from the University of Oxford and an MBA from Insead.

Contacts

Tecmaia – Parque de Ciência e Tecnologia da Maia
Rua Eng.º Frederico Ulrich, 2650
4470-605 Maia
Portugal

+351 220 968 183
info@healthportugal.com